Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) has received a consensus rating of “Moderate Buy” from the fifteen brokerages that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $26.67.
A number of equities analysts recently commented on the company. Wall Street Zen upgraded Omada Health from a “hold” rating to a “buy” rating in a report on Sunday, October 11th. Needham & Company LLC reiterated a “buy” rating and set a $28.00 price target on shares of Omada Health in a research note on Friday, September 11th. Canaccord Genuity Group boosted their price target on shares of Omada Health from $24.00 to $28.00 and gave the stock a “buy” rating in a research note on Tuesday, July 21st. Zacks Research raised shares of Omada Health from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 6th. Finally, Robert W. Baird raised their price objective on shares of Omada Health from $15.00 to $25.00 and gave the company a “neutral” rating in a research note on Wednesday, August 12th.
Get Our Latest Stock Report on OMDA
Insider Buying and Selling at Omada Health
In other Omada Health news, CEO Sean Duffy sold 17,258 shares of the business’s stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $20.68, for a total value of $356,895.44. Following the completion of the transaction, the chief executive officer owned 382,594 shares in the company, valued at $7,912,043.92. The trade was a 4.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, President Wei-Li Shao sold 4,036 shares of the business’s stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $21.85, for a total transaction of $88,186.60. Following the completion of the transaction, the president owned 295,313 shares of the company’s stock, valued at approximately $6,452,589.05. This trade represents a 1.35% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 127,642 shares of company stock valued at $2,915,201 in the last 90 days. Corporate insiders own 6.38% of the company’s stock.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of OMDA. Sterling Capital Management LLC boosted its stake in shares of Omada Health by 1,161.6% in the 3rd quarter. Sterling Capital Management LLC now owns 1,577 shares of the company’s stock valued at $33,000 after buying an additional 1,452 shares during the period. Robeco Institutional Asset Management B.V. purchased a new stake in shares of Omada Health during the third quarter worth approximately $1,100,000. Counterpoint Mutual Funds LLC acquired a new stake in Omada Health in the third quarter valued at approximately $595,000. State of Alaska Department of Revenue acquired a new stake in Omada Health in the third quarter valued at approximately $59,000. Finally, WINTON GROUP Ltd acquired a new stake in Omada Health in the second quarter valued at approximately $1,101,000.
Omada Health Stock Up 1.5%
OMDA opened at $19.24 on Tuesday. Omada Health has a 52 week low of $10.28 and a 52 week high of $26.92. The business has a fifty day simple moving average of $21.13 and a 200-day simple moving average of $17.63. The firm has a market cap of $1.18 billion, a P/E ratio of 384.80 and a beta of 2.03.
Omada Health (NASDAQ:OMDA – Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.10. The business had revenue of $87.83 million during the quarter, compared to analysts’ expectations of $80.93 million. Omada Health had a return on equity of 2.60% and a net margin of 1.39%. Sell-side analysts expect that Omada Health will post 0.09 earnings per share for the current year.
About Omada Health
Omada Health, Inc (NASDAQ: OMDA) is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines personalized health coaching, clinical support, behavioral-change tools and connected devices to help members monitor and improve their health.
The company’s offerings focus primarily on cardiometabolic conditions, including diabetes, prediabetes, hypertension and obesity, as well as musculoskeletal conditions. Depending on the program, members may receive access to digital lessons, health tracking, remote monitoring, care teams and clinical guidance through Omada’s technology platform.
Omada Health was founded in 2011 and serves employers, health plans and other healthcare organizations in the United States.
Further Reading
- Five stocks we like better than Omada Health
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.
